Nitric oxide mediates cyclosporine-induced apoptosis in cultured renal cells

A Amore1, S N Emancipator, P Cirina

  • 1Nephrology and Dialysis Department, Central Laboratory, Regina Margherita Children's Hospital, Torino, Italy. amorenefro@email.oirmsantanna.piemonte.it

Kidney International
|April 12, 2000
PubMed
Abstract

Insights

Cyclosporine (CsA) causes kidney cell apoptosis by increasing nitric oxide synthase (NOS). Inhibiting NOS or p53 may prevent CsA-induced nephrotoxicity, potentially reducing fibrosis.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Cell Biology

Background:

  • Cyclosporine (CsA) use is limited by nephrotoxicity.
  • Apoptosis, potentially mediated by nitric oxide synthase (NOS) activity, may contribute to CsA-induced kidney damage.

Purpose of the Study:

  • To investigate the role of apoptosis and nitric oxide synthase (NOS) in cyclosporine (CsA)-induced nephrotoxicity.
  • To examine the effects of CsA on apoptosis and NOS activity in various renal and endothelial cell lines.

Main Methods:

  • Human and murine cell lines were treated with CsA (0-1000 ng/mL) for 4-24 hours.
  • Apoptosis was assessed via TUNEL assay and DNA fragmentation.
  • Nitric oxide synthase (NOS) activity, iNOS mRNA, and iNOS protein expression were evaluated, with and without apoptosis inhibitors L-nitromethylarginine (L-NAME) and cycloheximide (CHX).

Main Results:

  • CsA significantly increased apoptosis in all cell lines in a dose-dependent manner.
  • CsA elevated NOS activity, which was inhibited by L-NAME and CHX.
  • CsA induced iNOS and p53 protein expression, with CHX inhibiting both and L-NAME inhibiting only p53.

Conclusions:

  • Cyclosporine (CsA) induces apoptosis in renal cells through the induction of inducible nitric oxide synthase (iNOS) via p53.
  • These findings suggest a mechanism for CsA nephrotoxicity and potential therapeutic targets.